Czechia - Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics

Since 2014, Czechia Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics was up 4.4% year on year. In 2019, the country was number 16 among other countries in Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics at €489,401,830.24. Czechia is overtaken by Finland, which was ranked number 15 at €595,029,299.45 and is followed by Romania at €458,233,501.88. Germany lead the ranking with €16,376,860,638.2 in 2019, an increase of 0.5% compared to 2018. Ireland, France and United Kingdom respectively ranked number 2, 3 and 4 in this ranking. Sweden witnessed the best average annual growth at +62.7% per year, while Montenegro recorded the worst performance at -6.3% per year.

Loading...

Date Euros
2019 489,401,830.24
2018 465,975,709.00
2017 481,362,417.00
2016 472,027,632.00
2015 445,812,530.00
Download all data from 2001 to 2019

How does Czechia rank in Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics?

# 29 Countries Euros Last YoY 5‑years CAGR
1 #1
Germany
16,376,860,638.20 2019 +0.5 % +3.5 % View data
2 #2
Ireland
14,139,386,320.45 2019 +21.9 % -5.8 % View data
15 #15
Finland
595,029,299.45 2019 +3.0 % -0.1 % View data
16 #16
Czechia
489,401,830.24 2019 +5.0 % +4.4 % View data
17 #17
Romania
458,233,501.88 2019 +5.4 % -1.4 % View data
Compare all 29 countries

Go Top